Zou S - Search Results

1

A Novel Approach Using FDG-PET/CT-Based Radiomics to Assess Tumor Immune Phenotypes in Patients With Non-Small Cell Lung Cancer.

Zhou J, Zou S, Kuang D, Yan J, Zhao J, Zhu X. Zhou J, et al. Among authors: zou s. Front Oncol. 2021 Nov 17;11:769272. doi: 10.3389/fonc.2021.769272. eCollection 2021. Front Oncol. 2021. PMID: 34868999 Free PMC article.

2

Monitoring Hepatocyte Dysfunction and Biliary Complication After Liver Transplantation Using Quantitative Hepatobiliary Scintigraphy.

Zou SJ, Chen D, Li YZ, Du DF, Chen ZS, Zhu XH. Zou SJ, et al. Medicine (Baltimore). 2015 Nov;94(45):e2009. doi: 10.1097/MD.0000000000002009. Medicine (Baltimore). 2015. PMID: 26559297 Free PMC article.

3

Novel Glypican-3-Binding Peptide for in Vivo Hepatocellular Carcinoma Fluorescent Imaging.

Zhu D, Qin Y, Wang J, Zhang L, Zou S, Zhu X, Zhu L. Zhu D, et al. Among authors: zou s. Bioconjug Chem. 2016 Mar 16;27(3):831-9. doi: 10.1021/acs.bioconjchem.6b00030. Epub 2016 Feb 19. Bioconjug Chem. 2016. PMID: 26850086

4

Adult B-Cell Acute Lymphoblastic Leukemia Dominated by Osteolytic Bone Involvement on CT But Less Impressive PET on FDG PET/CT Images.

Zou S, Shen Y, Zhu D, Zhang D, Zhu X. Zou S, et al. Clin Nucl Med. 2017 Jun;42(6):467-470. doi: 10.1097/RLU.0000000000001653. Clin Nucl Med. 2017. PMID: 28368891

5

Prognostic Value of 99mTc-Sestamibi Parathyroid Scintigraphy in Predicting Future Surgical Eligibility in Patients With Asymptomatic Primary Hyperparathyroidism.

Cheng Z, Zou S, Peng D, Zhang G, Zhu X. Cheng Z, et al. Among authors: zou s. Clin Nucl Med. 2018 Mar;43(3):151-154. doi: 10.1097/RLU.0000000000001941. Clin Nucl Med. 2018. PMID: 29261636

6

Immuno-PET Imaging of ⁸⁹Zr Labeled Anti-PD-L1 Domain Antibody.

Li D, Cheng S, Zou S, Zhu D, Zhu T, Wang P, Zhu X. Li D, et al. Among authors: zou s. Mol Pharm. 2018 Apr 2;15(4):1674-1681. doi: 10.1021/acs.molpharmaceut.8b00062. Epub 2018 Mar 12. Mol Pharm. 2018. PMID: 29502426

7

Anal Malignant Melanoma Manifesting Hepatic Metastases Shown on FDG PET/CT.

Zou S, Cheng Z, Song S, Kuang D, Zhu X. Zou S, et al. Clin Nucl Med. 2018 May;43(5):386-388. doi: 10.1097/RLU.0000000000002056. Clin Nucl Med. 2018. PMID: 29517546

8

Elevated 68Ga-DOTATATE Activity in IgG4-Related Lymphadenopathy.

Cheng Z, Song S, Han Y, Zou S, Zhu X. Cheng Z, et al. Among authors: zou s. Clin Nucl Med. 2018 Oct;43(10):773-776. doi: 10.1097/RLU.0000000000002223. Clin Nucl Med. 2018. PMID: 30059434

9

Telbivudine-Induced Myopathy Incidentally Detected by FDG PET/CT Imaging in a Patient With History of Hepatocellular Carcinoma.

Zou S, Cheng Z, Song S, Zhu D, Zhu X. Zou S, et al. Clin Nucl Med. 2019 Feb;44(2):171-172. doi: 10.1097/RLU.0000000000002385. Clin Nucl Med. 2019. PMID: 30608913

10

Concurrent Metastatic Pheochromocytomas and Lung Adenocarcinoma on 18F-FDG and 68Ga-DOTATATE PET/CT Images.

Cheng Z, Zou S, Song S, Zhu X. Cheng Z, et al. Among authors: zou s. Clin Nucl Med. 2019 Sep;44(9):754-756. doi: 10.1097/RLU.0000000000002588. Clin Nucl Med. 2019. PMID: 31021913

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,120 results

Search Page

Filters